ArticlebioRxiv : the preprint server for biology2026
Composite Biofidelity: Addressing Metric Degeneracy in Biomechanical Model Validation and Machine Learning Loss Design.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Spectral similarity is often judged with a single metric such as RMSE, yet this can be misleading: physically different errors can produce similar scores. This is a critical limitation for computational biomechanics, where spectral agreement underpins both model validation and machine-learning loss design. Here, we develop a multi-metric framework for objective spectral biofidelity and test whether it better captures meaningful disagreement across complex frequency-domain responses. We evaluated 12 complementary similarity metrics, including CORA and ISO/TS 18571, using controlled spectral perturbations that mimic common real-world deviations such as resonance shifts, localized spikes, and broadband tilts. We then applied the framework to an SBI-tuned finite-element middle-ear model to assess convergence with training dataset size and robustness to measurement noise across repeated stochastic runs. No single metric performed reliably across all distortion types. Shape-based metrics tracked resonance morphology but could miss vertical scaling, whereas MaxError remained important for narrowband anomalies that smoother metrics underweighted. CORA and ISO 18571 did not consistently outperform simpler metrics. Rank aggregation using Borda count provided a robust consensus across metrics, enabling objective identification of training-data saturation and noise thresholds beyond which similarity rankings became unstable. These results show that spectral biofidelity cannot be reduced to a single norm. A multi-metric consensus provides a clearer and more physically meaningful basis for comparing experimental and simulated spectra, and offers a more defensible foundation for data-fidelity terms in physics-informed and simulation-based machine learning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.